Hospital San Pedro-ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2024

  1. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach

    Antibiotics, Vol. 13, Núm. 6

2021

  1. Penicillin susceptibility among invasive MSSA infections: A multicentre study in 16 Spanish hospitals

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2519-2527

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 7, pp. 1062-1070

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

  2. Multicenter study of clinical non-β-lactam-antibiotic susceptible MRSA strains: Genetic lineages and Panton-Valentine leukocidin (PVL) production

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 509-513

  3. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients

    Medicina Clinica, Vol. 150, Núm. 8, pp. 291-296

  2. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

  3. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

    AIDS, Vol. 32, Núm. 11, pp. 1423-1430

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2010

  1. Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 4, pp. 215-221

2009

  1. Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

    BMC Infectious Diseases, Vol. 10

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

  2. Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 11, pp. 1196-1202

  3. Rickettsia monacensis and human disease, Spain

    Emerging Infectious Diseases, Vol. 13, Núm. 9, pp. 1405-1407

1999

  1. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy

    AIDS, Vol. 13, Núm. 12, pp. 1497-1502